These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15297182

  • 1. Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.
    Tuhkanen H, Anttila M, Kosma VM, Puolakka J, Juhola M, Heinonen S, Mannermaa A.
    Gynecol Oncol; 2004 Aug; 94(2):416-21. PubMed ID: 15297182
    [Abstract] [Full Text] [Related]

  • 2. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW, Zanotti KM, Kennedy AW, Belinson JL, Casey G.
    Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
    [Abstract] [Full Text] [Related]

  • 3. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A.
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [Abstract] [Full Text] [Related]

  • 4. Human APC2 localization and allelic imbalance.
    Jarrett CR, Blancato J, Cao T, Bressette DS, Cepeda M, Young PE, King CR, Byers SW.
    Cancer Res; 2001 Nov 01; 61(21):7978-84. PubMed ID: 11691822
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D, Moreno-Bueno G, Sánchez-Estévez C, Bañón-Rodríguez I, Hernández-Cortés G, Hardisson D, Palacios J.
    Hum Pathol; 2006 Aug 01; 37(8):1042-9. PubMed ID: 16867867
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.
    Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J, Smith DI.
    Cancer Res; 2002 Jan 01; 62(1):262-70. PubMed ID: 11782386
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT.
    Nat Med; 2007 Jan 01; 13(1):78-83. PubMed ID: 17159988
    [Abstract] [Full Text] [Related]

  • 11. Genomic alterations associated with early stages of breast tumor metastasis.
    Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Hooke JA, Love B, Shriver CD.
    Ann Surg Oncol; 2008 Jul 01; 15(7):1989-95. PubMed ID: 18401664
    [Abstract] [Full Text] [Related]

  • 12. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F, Mes-Masson AM, Seymour RJ, Provencher D, Tonin PN.
    Oncogene; 2000 Mar 09; 19(11):1466-72. PubMed ID: 10723138
    [Abstract] [Full Text] [Related]

  • 13. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.
    Koed K, Wiuf C, Christensen LL, Wikman FP, Zieger K, Møller K, von der Maase H, Orntoft TF.
    Cancer Res; 2005 Jan 01; 65(1):34-45. PubMed ID: 15665277
    [Abstract] [Full Text] [Related]

  • 14. A commonly deleted region in ovarian cancer on chromosome 19p13.3, not including the OAZ1 gene.
    Yanaihara N, Okamoto A, Matsufuji S.
    Int J Oncol; 2003 Sep 01; 23(3):567-75. PubMed ID: 12888889
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA, Shen Z, Ripeau JS, Provencher DM, Mes-Masson AM, Chevrette M, Tonin PN.
    Mol Carcinog; 2009 Dec 01; 48(12):1077-92. PubMed ID: 19347865
    [Abstract] [Full Text] [Related]

  • 16. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
    Bandera CA, Takahashi H, Behbakht K, Liu PC, LiVolsi VA, Benjamin I, Morgan MA, King SA, Rubin SC, Boyd J.
    Cancer Res; 1997 Feb 01; 57(3):513-5. PubMed ID: 9012483
    [Abstract] [Full Text] [Related]

  • 17. Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C, Yu M, Shan L, Snyderwine EG.
    Oncogene; 2003 Feb 27; 22(8):1253-60. PubMed ID: 12606953
    [Abstract] [Full Text] [Related]

  • 18. Allelic imbalance in hereditary and sporadic prostate cancer.
    Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA.
    Prostate; 2003 Jan 01; 54(1):50-7. PubMed ID: 12481255
    [Abstract] [Full Text] [Related]

  • 19. Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.
    Ellsworth RE, Ellsworth DL, Neatrour DM, Deyarmin B, Lubert SM, Sarachine MJ, Brown P, Hooke JA, Shriver CD.
    Mol Cancer Res; 2005 Feb 01; 3(2):71-7. PubMed ID: 15755873
    [Abstract] [Full Text] [Related]

  • 20. Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping.
    Pesti T, Sükösd F, Jones EC, Kovacs G.
    Hum Pathol; 2001 Jan 01; 32(1):101-4. PubMed ID: 11172302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.